Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 3
1981 3
1982 1
1983 3
1984 4
1985 10
1986 7
1987 5
1988 9
1989 4
1990 13
1991 5
1992 4
1993 3
1994 5
1995 5
1996 6
1997 7
1998 8
1999 8
2000 11
2001 17
2002 8
2003 7
2004 7
2005 9
2006 14
2007 11
2008 9
2009 8
2010 11
2011 19
2012 14
2013 11
2014 18
2015 17
2016 19
2017 16
2018 10
2019 10
2020 11
2021 11
2022 11
2023 10
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

383 results

Results by year

Filters applied: . Clear all
Page 1
[Skin aging: Pathophysiology and innovative therapies].
Boismal F, Serror K, Dobos G, Zuelgaray E, Bensussan A, Michel L. Boismal F, et al. Among authors: bensussan a. Med Sci (Paris). 2020 Dec;36(12):1163-1172. doi: 10.1051/medsci/2020232. Epub 2020 Dec 9. Med Sci (Paris). 2020. PMID: 33296633 Free article. Review. French.
ENTPD1/CD39 is a promising therapeutic target in oncology.
Bastid J, Cottalorda-Regairaz A, Alberici G, Bonnefoy N, Eliaou JF, Bensussan A. Bastid J, et al. Among authors: bensussan a. Oncogene. 2013 Apr 4;32(14):1743-51. doi: 10.1038/onc.2012.269. Epub 2012 Jul 2. Oncogene. 2013. PMID: 22751118 Review.
CD100 is a leukocyte semaphorin.
Delaire S, Elhabazi A, Bensussan A, Boumsell L. Delaire S, et al. Among authors: bensussan a. Cell Mol Life Sci. 1998 Nov;54(11):1265-76. doi: 10.1007/s000180050252. Cell Mol Life Sci. 1998. PMID: 9849618 Review.
CD160: a unique activating NK cell receptor.
Le Bouteiller P, Tabiasco J, Polgar B, Kozma N, Giustiniani J, Siewiera J, Berrebi A, Aguerre-Girr M, Bensussan A, Jabrane-Ferrat N. Le Bouteiller P, et al. Among authors: bensussan a. Immunol Lett. 2011 Aug 30;138(2):93-6. doi: 10.1016/j.imlet.2011.02.003. Epub 2011 Feb 13. Immunol Lett. 2011. PMID: 21324341 Review.
CCR8 is a new therapeutic target in cutaneous T-cell lymphomas.
Giustiniani J, Dobos G, Moins-Teisserenc H, Eustaquio T, Battistella M, Ortonne N, Ram-Wolff C, Bouaziz JD, Marie-Cardine A, Mourah S, Bagot M, Kupper TS, Clark RA, Bensussan A, de Masson A. Giustiniani J, et al. Among authors: bensussan a. Blood Adv. 2022 Jun 14;6(11):3507-3512. doi: 10.1182/bloodadvances.2021006512. Blood Adv. 2022. PMID: 35201316 Free PMC article. No abstract available.
CD160 receptor in CLL: Current state and future avenues.
Oumeslakht L, Aziz AI, Bensussan A, Ben Mkaddem S. Oumeslakht L, et al. Among authors: bensussan a. Front Immunol. 2022 Nov 7;13:1028013. doi: 10.3389/fimmu.2022.1028013. eCollection 2022. Front Immunol. 2022. PMID: 36420268 Free PMC article. Review.
Up-and-down immunity of pregnancy in humans.
Le Bouteiller P, Bensussan A. Le Bouteiller P, et al. Among authors: bensussan a. F1000Res. 2017 Jul 25;6:1216. doi: 10.12688/f1000research.11690.1. eCollection 2017. F1000Res. 2017. PMID: 28781765 Free PMC article. Review.
Early Elevated IFNα Identified as the Key Mediator of HIV Pathogenesis and its low level a Hallmark of Elite Controllers.
Le Buanec H, Schiavon V, Merandet M, How-Kit A, Bergerat D, Fombellida-Lopez C, Bensussan A, Bouaziz JD, Burny A, Darcis G, Song H, Sajadi MM, Kottilil S, Gallo RC, Zagury D. Le Buanec H, et al. Among authors: bensussan a. Res Sq [Preprint]. 2023 May 11:rs.3.rs-2813601. doi: 10.21203/rs.3.rs-2813601/v1. Res Sq. 2023. PMID: 37215045 Free PMC article. Updated. Preprint.
383 results